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ABSTRACT
Objective Proline–glycine–proline (PGP) has been
shown to have chemotactic effects on neutrophils via
CXCR2 in several lung diseases. PGP is derived from
collagen by the combined action of matrix
metalloproteinase (MMP) 8 and/or MMP9 and prolyl
endopeptidase (PE). We investigated the role of PGP in
inflammatory bowel disease (IBD).
Design In intestinal tissue from patients with IBD and
mice with dextran sodium sulfate (DSS)-induced colitis,
MMP8, MMP9 and PE were evaluated by ELISA,
immunoblot and immunohistochemistry. Peripheral blood
polymorphonuclear cell (PMN) supernatants were also
analysed accordingly and incubated with collagen to
assess PGP generation ex vivo. PGP levels were
measured by mass spectrometry, and PGP neutralisation
was achieved with a PGP antagonist and PGP
antibodies.
Results In the intestine of patients with IBD, MMP8
and MMP9 levels were elevated, while PE was expressed
at similar levels to control tissue. PGP levels were
increased in intestinal tissue of patients with IBD. Similar
results were obtained in intestine from DSS-treated mice.
PMN supernatants from patients with IBD were far more
capable of generating PGP from collagen ex vivo than
healthy controls. Furthermore, PGP neutralisation during
DSS-induced colitis led to a significant reduction in
neutrophil infiltration in the intestine.
Conclusions The proteolytic cascade that generates
PGP from collagen, as well as the tripeptide itself, is
present in the intestine of patients with IBD and mice
with DSS-induced colitis. PGP neutralisation in
DSS-treated mice showed the importance of PGP-guided
neutrophilic infiltration in the intestine and indicates a
vicious circle in neutrophilic inflammation in IBD.
INTRODUCTION
Neutrophils are key inflammatory cells in the
innate defence against invading pathogens. The
recruitment of neutrophils to the site of inflamma-
tion is controlled and directed by the release of
endogenous and/or pathogen-derived chemoattract-
ant signals.1 Classic endogenous chemoattractants
for neutrophils are CXC chemokines such as
CXCL8, CXCL1, CXCL2 and CXCL3 in humans
and CXCL1 and CXCL2 in mice.2 These chemo-
kines induce migration and activation by binding to
specific G-protein-coupled receptors on the surface
of neutrophils, mainly CXCR1 and CXCR2 in
humans and CXCR2 in mice.3
Fragments of the extracellular matrix, such as
collagen fragments, can also have chemotactic
properties.4 Recently, a collagen-derived fragment,
proline–glycine–proline (PGP), was shown to have
chemotactic effects on neutrophils via CXCR2.5
The tripeptide, PGP, is formed from collagen
by the combinational action of matrix metallopro-
teinases (MMPs) and prolyl endopeptidase
(or prolyl oligopeptidase) (PE).6 MMP8 and/or
MMP9 are responsible for cleavage of collagen into
smaller (<30 kDa) fragments, which allow further
cleavage by PE. Acetylation of PGP leads to
N-acetyl N-Ac-PGP, which is a more potent
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Significance of this study
What is already known on this subject?
▸ Proline–glycine–proline (PGP) is a
collagen-degradation product that mediates
neutrophil infiltration into the lung via CXCR2
in inflammatory lung diseases such as chronic
obstructive pulmonary disease and asthma.
▸ PGP is formed from collagen by the combined
action of matrix metalloproteinase (MMP) 8/9
and prolyl endopeptidase (PE).
▸ Both collagen proteolysis and neutrophil
infiltration are extensively present in
inflammatory bowel disease (IBD).
What are the new findings?
▸ The PGP generation cascade (MMP8/9 and PE)
and PGP itself are present in the intestines of
patients with IBD and mice with dextran
sodium sulfate (DSS)-induced colitis.
▸ PGP neutralisation reduced neutrophilic
infiltration in the intestine of DSS-treated mice.
How might it impact on clinical practice in
the foreseeable future?
▸ Our results show that reducing collagen
degradation in the intestine of patients with
IBD not only reduces intestinal damage, but
also reduces neutrophilic infiltration into the
intestine, which opens up new avenues for
treating the chronic inflammation found in IBD.
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chemoattractant for neutrophils than PGP itself.7 The formation
of PGP (and N-Ac-PGP) and subsequent neutrophilic infiltration
plays an important role in, and is a potential biomarker for,
chronic obstructive pulmonary disease and other lung diseases,
such as cystic fibrosis.5 8 9
In inflammatory bowel diseases (IBDs), with the clinical manifes-
tations Crohn’s disease (CD) and ulcerative colitis (UC), luminal
disease activity is accompanied by extensive neutrophilic inflamma-
tion.10 In addition to the role of chemokines and their receptors in
IBD,11 12 collagen remodelling and the role of MMPs have also
been extensively studied in this disease.13 Most of these MMPs
show enhanced expression and/or activity in the bowel of patients
with IBD. PE is found in all tissues including the intestine.14
Similarly, in vivo models of colitis, such as the dextran sodium
sulfate (DSS) model, are dependent on proteolytic enzymes.15 16
Moreover, blocking CXCR2 with antibodies or CXCR2 antago-
nists reduces DSS-induced colitis,17 and CXCR2 knock-out
animals are resistant to DSS-induced colitis.18
The aim of the present study was to investigate the components
of the collagen-degradation pathway that lead to the production of
PGP (MMP8, MMP9 and PE) in IBD. To determine the role of
PGP in neutrophilic migration in intestinal inflammation, we inves-
tigated these components and the effects of PGP neutralisation in
mice with DSS-induced colitis. We hypothesised that, in the bowel
of patients with IBD and in mice with DSS-induced colitis, colla-
gen breakdown leads to the production of PGP, enhancing neutro-
phil chemotaxis to the intestine and exaggerating the disease.
MATERIALS AND METHODS
Patient samples
Macroscopically inflamed/affected as well as non-inflamed/
unaffected intestinal mucosa from patients with IBD and colo-
rectal cancer controls was prospectively collected after surgical
resection at the Leiden University Medical Centre, The
Netherlands. The procedure for homogenising intestinal tissue
and methods of assaying myeloperoxidase (MPO) activity and
MMP9 protein levels have been reported previously.19 The char-
acteristics, MPO activities and MMP9 levels of the subpopula-
tion of patients used here are presented in online supplementary
figure S1(A–C). The patients in the polymorphonuclear cell
(PMN) study (online supplementary figure S1D) were recruited
at the Department of Gastroenterology in the Academic
Medical Centre, Amsterdam, The Netherlands. For all studies
with human samples, protocols were executed according to the
guidelines of the local medical ethics committee and in compli-
ance with the Helsinki Declaration.
Preparation of human samples for PGP measurement
Intestinal tissue homogenates (n=60) of the same patient resec-
tion material were made. Tissue was weighed and homogenised
in 1 mM bestatin/phosphate-buffered saline (PBS) (100 mg
tissue/ml) using a Precellys 24 tissue homogeniser (Bertin
Technologies, France) five times for 10 s at 6000 rpm with a
minimum 5 min cooling period on ice in between. Samples
were then centrifuged for 15 min at 14 000 rpm, and the super-
natant was transferred to a clean tube.
PMN studies and ex vivo PGP generation
PMNs were isolated from fresh peripheral blood from patients
with IBD and healthy controls as previously described,20 and
incubated (105 cells/well) in 100 μl RPMI medium 1640 (Lonza
Verviers SPRL, Verviers, Belgium) for 6 h. PMNs from healthy
controls were also incubated with 10 ng/ml lipopolysaccharide
(LPS) (Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands)
for 6 h. A 90 ml sample of this PMN-conditioned medium (105
cells/100 μl/well) was incubated with 10 ml of a 1 mg/ml solu-
tion of type I collagen (Sigma-Aldrich) in PBS for 24 h at 37°C
and 5% CO2 to assess collagen breakdown to (N-Ac-)PGP ex
vivo. The collagen was extensively dialysed beforehand to
remove PGP.
Measurement of PGP and N-Ac-PGP
Before peptide measurement, samples were 10 kDa-filtered
(Millipore). PGP and N-Ac-PGP levels in mouse samples and the
ex vivo PGP generation assay were analysed as described previ-
ously.5 Human intestinal samples were analysed using a Finnigan
TSQ Quantum Discovery Max quadrupole mass spectrometer
with electrospray ionisation (Thermo Fisher Scientific, San Jose,
California, USA) on an Atlantis dC18 column (100 mm×2.1 mm,
dp=3 μm; Waters Chromatography, Milford, Massachusetts, USA)
with an Atlantis dC18 pre-column (10 mm×2.1 mm, dp=3 μm;
Waters). Positive electrospray mass transitions were monitored at
270>70, 270>116 and 270>173 for PGP and 312>140,
312>112 and 312>70 for N-Ac-PGP.
Colitis induction
Human (hu)CXCR2 C57Bl6 knock-in animals were bred under
standard housing conditions with drinking water and food avail-
able ad libitum, and genotyped as described previously.21 Colitis
was induced in male huCXCR2 knock-in mice (8–12 weeks old)
by administration of 1.5% (w/v) DSS (MP Biomedicals, Aurora,
Ohio, USA; molecular mass=36 000–50 000 Da) in tap water
to the mice for 5 consecutive days. After a 10-day tap water
recovery phase, a second 5-day DSS period was instituted. Mice
were killed by CO2 suffocation. All animal studies were
approved by the ethics committee for animal studies of Utrecht
University.
PGP neutralisation protocols
The neutralising PGP antagonist, arginine–threonine–arginine
(RTR; 300 μg/100 μl PBS; Anaspec, San Jose, California, USA),
and polyclonal PGP antibody (30 μg/100 μl PBS; EZBiolabs,
Westfield, Indiana, USA) were administered by intravenous injec-
tion into the tail vein, every day from day 0 to day 6. Control
mice were intravenously injected daily with 100 μl PBS or
30 μg/100 μl isotype control (rabbit IgG; R&D Systems,
Minneapolis, Minnesota, USA).
Assessment of colitis
The presence of blood in faeces (0=none, 1=positive,
2=visible), stool consistency (0=normal, 1=loose stools,
2=diarrhoea) and general appearance (0=normal, 1=hunched
back, 2=lethargic) were recorded daily for each animal.
Together, these factors constitute the Disease Activity Index
(DAI, range 0–6), as described previously.22
Histopathology and intestinal tissue sampling
The large intestines of the killed mice were isolated, and the
length was measured in a relaxed position without stretching.
The large intestine was opened longitudinally, cleaned in PBS,
and longitudinally divided into two pieces. One part was
embedded in paraffin (Swiss-role technique), and the other part
was stored at −80°C until homogenisation in 1 ml ice-cold PBS
as described previously.23 Protein concentration was determined
using the BCA protein assay kit (Thermo Fisher Scientific).
Histology of standard H&E slides was scored in a blinded
fashion by scoring crypt loss and influx of inflammatory cells
with a number from 0 (normal) to 4 (severe), and for the
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amount of affected colon (1, <25%; 2, 25–50%; 3, 50–75%;
4, 75–100%). The sum of these scores is the histological
score (0–16).
Immunohistochemistry
Immunohistochemistry was performed as described previously.22
Antigen retrieval was carried out by boiling the slides in 10 mM
citrate buffer (pH 6.0) for 10 min in a microwave oven. The
slides were blocked with 5% goat serum (Dakocytomation,
Glostrup, Denmark) in 1% BSA in PBS for 20 min at room tem-
perature. The sections were then incubated with primary anti-
bodies (rabbit anti-MMP8 (1:400 dilution; Lifespan
Biosciences; LS-C48493), rabbit anti-MMP924 (1:400 dilution),
rabbit anti-PE (1:500 dilution; ProteinTech Group, USA) or rat
anti-mouse Ly-6B.2 (1:400 dilution; AbD Serotec, UK;
MCA771GA)) in 1% BSA/PBS overnight at 4°C. Detection was
carried out with biotinylated goat anti-rabbit secondary anti-
bodies (1:200 dilution; Dakocytomation), streptavidin–avidin–
biotin complex/horseradish peroxidase (HRP) (Vectastain Elite
ABC; Vector Laboratories) and diaminobenzidine tetrahy-
drochloride (Sigma-Aldrich). Sections were counterstained with
Mayer’s haematoxylin (Merck), dehydrated and mounted. Slides
that had not been incubated with primary antibody were
included as negative controls. Photomicrographs were taken
with an Olympus BX50 microscope equipped with a Leica DFC
320 digital camera.
Quantification of CXCL1, CXCL2, MMP8, MMP9, leukotriene
B4 (LTB4) and MPO
MMP8 (human: R&D systems; mouse: Cusabio Biotech), LTB4
(R&D systems) and total and pro-MMP9 (both R&D Systems)
concentrations and MPO activity (Mouse MPO ELISA Kit;
Hycult Biotechnology, Uden, The Netherlands) were deter-
mined using ELISA kits. The concentration of active MMP9 was
calculated by subtracting pro-MMP9 from total MMP9. The
levels of CXCL1 and CXCL2 were measured using a mouse
multiplex assay according to the manufacturer’s instructions
(Millipore Corporation, Billericia, Massachusetts, USA). MMP8
and MMP9 levels in PMN-conditioned medium were quantified
using a Fluorokine MAP Human Base Kit (R&D Systems).
Gelatin zymography
The presence of active and latent forms of MMP9 was analysed
by zymography on 11% polyacrylamide gel containing 1%
porcine skin gelatin (Sigma-Aldrich) as previously described.24
Assay of PE activity
PE activity was measured using the fluorogenic substrate,
Z-Gly-Pro-7-amido-4-methylcoumarin (Z-GP-AMC; Bachem,
Budendorf, Germany), as described previously.25 Tissue hom-
ogenate (20 ml; 5 μg) or PMN-conditioned medium (20 ml) was
incubated with 80 ml assay buffer (100 mM Z-GP-AMC in
25 mM Tris/HCl, 0.25 M NaCl, pH 7.5, 2 mM DTT) at 37°C.
The fluorescence from released AMC was monitored using a
Fluostar reader at an excitation wavelength of 355 nm and an
emission wavelength of 460 nm. Fluorimetric intensities
observed were converted into pmol AMC released per minute
using appropriate AMC standard curves. PE activity was
expressed as pmol AMC/min or pmol AMC/min/mg protein.
Immunoblotting
Homogenates were separated on 10% (w/v) SDS gels and blotted
on to nitrocellulose membranes (Millipore). Membranes were
blocked for 1 h with 5% milk proteins in PBST (PBS+0.1%
Tween 20) and subsequently incubated with mouse anti-human
MMP8 (1:500 dilution; R&D systems; MAB9081), rabbit
anti-MMP8 (1:500 dilution; Lifespan Biosciences; LS-C48493)
or rabbit anti-PE (1:500 dilution; EZBiolabs) in 2% milk/PBST
overnight at 4°C. Afterwards, membranes were incubated
with HRP-labelled secondary antibodies (1:2000 dilution;
Dakocytomation) in 2% milk/PBST, treated with commercial ECL
reagents (Amersham Biosciences, Roosendaal, The Netherlands)
and finally exposed to photographic film. Blots were then stripped
with stripping buffer (Thermo Fisher Scientific) and reprobed with
rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH;
1:5000 dilution; ITK Diagnostics, Uithoorn, The Netherlands).
Statistical analysis
Statistical significance of differences between groups was deter-
mined by paired t test, unpaired t test, Mann–Whitney U test,
Wilcoxon signed rank test, or one-way analysis of variance fol-
lowed by Dunnett’s multiple comparison test using GraphPad
Prism 4.0 or SPSS V.16.0. Results were considered significant
when p<0.05.
RESULTS
Protease expression in IBD
MMP8 levels (figure 1A) were found to be increased in inflamed
IBD intestinal tissue homogenates compared with non-inflamed
IBD and control tissue, similar to MMP9 levels (see online sup-
plementary figure S1B).19 Investigation of MMP8 levels by
immunoblotting showed that the majority of the expressed
MMP8 is the active form (figure 1C). There were no differences
in MMP8 expression in tissue from patients with UC or CD, or
in intestinal location (data not shown). There was a strong cor-
relation between MMP8 level (Spearman’s r=0.557, p<0.001)
and MPO activity. Thus, both MMP8 and MMP9, the proteases
necessary for the initial collagen-cleavage step, were present in
the inflamed bowel specimens obtained from patients with IBD.
PE activity in IBD
As PE is responsible for cleaving the smaller collagen fragments
into PGP, we measured PE activity in the same panel of IBD
intestinal tissue homogenates. The activity of PE was similar in
control tissue and inflamed and non-inflamed IBD samples
(figure 1B). There was also no difference between tissue from
patients with UC or CD, or in intestinal location (data not
shown). This was confirmed by immunoblotting (figure 1C). In
all tissues, a single band was detected at 81 kDa, which is the
active PE form, as there is no proenzyme form.14
Protease expression in the intestine of patients with IBD
We were interested to determine which cells produce the pro-
teases, MMP8, MMP9 and PE, and if they colocalise within the
intestine, enabling generation of PGP from collagen. MMP9
was mainly present in infiltrating immune cells such as neutro-
phils and macrophages (figure 1D). Weak expression of MMP8
in epithelial cells in addition to expression in inflammatory cells
was found in some patient samples (figure 1D), as reported pre-
viously.26 PE was expressed in both epithelial cells and inflam-
matory cells, including neutrophils (figure 1D). To confirm PE
production by intestinal epithelial cells, HT29 and Caco2 cells
were cultured in vitro. Both cell lines produced and secreted PE
(data not shown).
PGP generation in the intestine of patients with IBD
Measurement of PGP and N-Ac-PGP in intestinal tissue homo-
genates showed that N-Ac-PGP levels were significantly higher
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in IBD intestinal tissue samples (figure 2A), while there was a
trend towards increased PGP levels (figure 2B). We investigated
whether PGP degradation was enhanced in the intestine of
patients with IBD. Leukotriene A4 hydrolase (LTA4H) is capable
of degrading PGP,27 and may also be increased during inflamma-
tion. LTA4H activity in intestinal tissue homogenates can be
measured indirectly by measuring LTB4. There were no differ-
ences in LTB4 levels in inflamed versus non-inflamed or control
intestinal tissue homogenates (online supplementary figure S2),
and therefore no increase in LTA4H activity in IBD.
PMNs and PGP generation in IBD
During inflammation and collagen degradation, MMP8, MMP9
and PE are essential proteases involved in PGP generation, and
they can all be produced by neutrophils.28 To investigate
whether these specific proteases are increased in PMNs from
patients with IBD, PMNs isolated from peripheral blood of
healthy controls and patients were incubated for 6 h with
medium. Subsequently, MMP8, MMP9 and PE levels were mea-
sured in the conditioned medium. Both MMP8 and MMP9
were significantly enhanced in IBD PMNs compared with
healthy control PMNs (figure 3A,B), while the released PE activ-
ity was similar (figure 3C). This correlates with the data from
the tissue homogenates: increased MMP8 and MMP9 at
inflamed sites compared with non-inflamed/control samples,
and similar PE activity. To investigate if the proteases released
by the PMNs were capable of generating (N-Ac-)PGP ex vivo,
PMN-conditioned medium was incubated with type I collagen.
This showed that PMNs from patients with IBD are much more
potent in forming N-Ac-PGP from collagen than healthy control
Figure 1 Protease expression in
inflammatory bowel disease (IBD).
Matrix metalloproteinase 8 (MMP8)
protein concentration (A) and prolyl
endopeptidase (PE) activity (B) in
homogenates of inflamed (infl; n=50)
and non-inflamed (non-infl; n=42)
intestinal tissue from patients with IBD
and colorectal cancer controls (n=20).
Individual values are shown, and
horizontal lines represent mean values.
Statistical analysis was by unpaired t
test and paired t test. (C) MMP8 and
PE immunoblot on control samples
(C) and paired non-inflamed (N) and
inflamed (I) samples of five patients
with IBD, with
glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) as a loading
control. (D) Immunohistochemistry of
MMP8, MMP9 and PE (and negative
control) in intestinal tissues of a
patient with IBD. The MMP9, PE and
negative control shown were on
consecutive sections of the same tissue
sample. Original magnification ×400.
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PMNs (figure 3D). PGP levels were also increased, although not
significantly (figure 3E). To examine if this difference in neutro-
phil function was a consequence of the activation state of the
neutrophil, PMNs from healthy controls were exposed to the
bacterial toxin, LPS. After LPS exposure, PMNs from healthy
controls were capable of generating PGP from collagen (online
supplementary figure S3). This suggests that, in areas with
massive neutrophil infiltration in the intestine of patients with
IBD, there is the potential to produce high amounts of (N-Ac-)
PGP.
Proteases and PGP generation in the DSS-induced colitis
model
To determine the role of PGP in intestinal neutrophilic inflam-
mation by PGP neutralisation, we investigated the generation of
PGP in the DSS-induced colitis model in mice. Because there
are species differences in CXCR2-binding characteristics and
signalling, we used huCXCR2 knock-in mice21 to mimic the
human situation more closely.
MMP8, MMP9, PE activity and PGP levels were investigated
during two 5-day cycles of 1.5% (w/v) DSS with a 10-day
normal tap water period in between. The animals had clinico-
pathological signs of colitis, including moderate body weight
loss (online supplementary figure S4A), bloody diarrhoea
(online supplementary figure S4B), reduced colon length (online
supplementary figure S4C), and increased histopathological
scores (online supplementary figure S4D) including increased
infiltration of neutrophils, assessed by MPO activity (online sup-
plementary figure S4E), during these cycles. Similar to human
IBD, there was no significant increase in intestinal PE activity in
the DSS-induced colitis model (figure 4A,B), while MMP9
(both total and active) levels were elevated in the inflamed intes-
tine (figure 4C,D). MMP8 was also slightly elevated (figure 4E)
and mainly present in the active form (figure 4F). MMP9 was
expressed in infiltrating leucocytes, and MMP8 and PE were
found in both infiltrating leucocytes and epithelial cells
(figure 5A). As found for human intestinal samples, the gener-
ation of both PGP and N-Ac-PGP was evident in intestinal
samples (figure 5B,C). There was a strong trend towards
increased (N-Ac-)PGP levels in DSS-induced colitis (day 8 vs
day 0, p=0.09).
LTB4 levels also remained unchanged during the first DSS
cycle (online supplementary figure S5A). The other neutrophil
chemoattractants in mice, CXCL1 and CXCL2, were elevated
during the first DSS cycle (online supplementary figure S5B,C),
similar to CXCL8 in human IBD.29 So the protease expression
pattern, (N-Ac)PGP formation and LTA4H activity in the
DSS-induced colitis model were all similar to that found in IBD
patient samples, making this model suitable for studying the
effects of (N-Ac-)PGP neutralisation on neutrophil infiltration in
the intestine.
Therapeutic intervention by PGP neutralisation
Because the (N-Ac-)PGP elevation during the first DSS cycle was
similar to the elevation found in the intestinal IBD samples, we
investigated the effect of PGP neutralisation in this first DSS
cycle, by daily treatment with either a PGP-neutralising anti-
body27 or the complementary peptide sequence, arginine–threo-
nine–arginine (RTR).30 PGP neutralisation did not have a
profound effect on the mild reduction in body weight (data not
shown). However, it caused amelioration of wasting of the
disease, as judged by a reduction in the other clinicopathological
Figure 2 Proline–glycine–proline
(PGP) and N-Ac-PGP levels in
inflammatory bowel disease (IBD).
Intestinal N-Ac-PGP (A) and PGP (B)
levels in colorectal cancer controls
(n=5) and patients with IBD (inflamed
(infl), n=25; non-inflamed (non-infl),
n=18). Non-inflamed and inflamed
values were averaged per patient
resulting in one intestinal (N-Ac-)PGP
value per patient (IBD, n=27).
Individual values, expressed as ng
(N-Ac-)PGP/g intestinal tissue, are
shown, and horizontal lines represent
mean values. *p<0.05, unpaired t test.
Figure 3 Protease expression and proline–glycine–proline (PGP) generation by polymorphonuclear cells (PMNs) from patients with inflammatory
bowel disease (IBD). Matrix metalloproteinase 8 (MMP8) (A) and MMP9 (B) protein levels and prolyl endopeptidase (PE) activity (C) in conditioned
medium of PMNs isolated from peripheral blood of patients with IBD (n=15–20) and healthy controls (n=12). N-Ac-PGP (D) and PGP (E) generation
from collagen type I by PMN conditioned medium (IBD, n=12; control, n=8). Individual values are shown, and horizontal lines represent mean
values. Mann–Whitney tests were used to determine significance. *Values above trendline were not used to calculate significance. AMC,
7-amido-4-methylcoumarin.
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characteristics of DSS-induced colitis, compared with their
respective controls (PBS or isotype antibody treatment)
(figure 6A). There were no effects of PGP neutralisation on
control (water-treated) animals (data not shown). Both the DAI
and the shortening of the colon (figure 6B) were significantly
reduced at day 7. Histopathological analysis revealed a signifi-
cant decrease in the histopathological scores due to PGP neu-
tralisation (figure 6C,D). Moreover, investigation of neutrophil
infiltration by immunohistochemistry (figure 6E) and MPO
levels (figure 6F) showed that PGP neutralisation significantly
reduced neutrophil infiltration in the colon of DSS-treated mice.
The levels of CXCL1 and CXCL2 (online supplementary
figure S6A,B) and total and active MMP9 levels (online supple-
mentary figure S7A,B) in the intestine were decreased by PGP
neutralisation in DSS-induced colitis.
DISCUSSION
Neutrophils are rapidly recruited to sites of infection in
response to ELR+ CXC chemokines, such as CXCL8 in humans
and CXCL1and CXCL2 in mice.2 In IBD and DSS-induced
colitis, these chemokines are elevated in the intestine.11 12 We
now show that, besides these classic neutrophil
chemoattractants, a collagen-derived tripeptide, PGP, also plays
an important role in neutrophilic inflammation in IBD. PGP is
generated from collagen by the combined action of MMP8,
MMP9 and PE. Our studies identified a previously unrecognised
role of these proteases in IBD.
We found that MMP8 and MMP9 are mainly expressed by
inflammatory cells in the intestine, and levels of both are
increased in IBD, similar to results of others. The other protease
involved in the PGP generation cascade,6 PE, may be involved
in peptide degradation during nutrient absorption in the gut.14
To our knowledge, this is the first report of an investigation of
PE activity and protein levels in the intestine of patients with
IBD. PE expression and activity were found in the intestine of
patients with IBD as well as in control tissue, but there was no
difference in inflamed versus non-inflamed or control. In con-
trast with MMP8 and MMP9, PE was mainly expressed by epi-
thelial cells.
If MMP8 or MMP9 activity is the limiting step in the gener-
ation of PGP, one would expect more PGP generation during
intestinal inflammation, as PE is already present in healthy intes-
tinal tissue and MMP8 and MMP9 are greatly increased during
intestinal inflammation. We indeed found a significant increase
Figure 4 Proteases in dextran sodium sulfate (DSS)-induced colitis. Intestinal prolyl endopeptidase (PE) activity (A) of huCXCR2 knock-in mice
treated with 2-day cycles of DSS over time confirmed by immunoblot with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a loading control
(B). Active and total matrix metalloproteinase 9 (MMP9) levels (C) were confirmed by zymography (D), and MMP8 levels (E) were confirmed by
immunoblot with GAPDH as a loading control (F). All values are mean+SEM (n=3–8). *p<0.05 versus day 0 (control); **p<0.01 versus day
0. Statistical analysis was by one-way analysis of variance followed by Dunnett’s multiple comparison test. AMC, 7-amido-4-methylcoumarin.
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in N-Ac-PGP in intestinal tissue from patients with IBD, and
there was also a trend towards increased PGP levels. Collagen
type I is the type of collagen that is most abundantly found in
the intestine.31 Human neutrophils can contain MMP8, MMP9
and PE and are capable of generating PGP from collagen type I
on activation.28 Because circulating neutrophils from patients
with IBD are more activated,32 we hypothesised that PMNs iso-
lated from peripheral blood of such patients release more pro-
teases and are more capable of generating PGP from collagen.
Indeed we found that PMNs from patients with IBD release
more MMP8 and MMP9 and have similar PE levels under
unstimulated conditions than PMNs from healthy controls.
Moreover, conditioned medium from PMNs obtained from
patients with IBD are capable of producing PGP from collagen
under unstimulated conditions, in contrast with conditioned
medium from PMNs obtained from healthy controls. Activating
healthy control PMNs with LPS led to increased MMP8,
MMP9 and PE release from healthy control PMNs and PGP
generation from collagen, characteristics similar to those of
IBD patient PMNs. As PE is mainly expressed by epithelial
cells, high concentrations of PGP could be produced in the epi-
thelium, which in turn results in a chemotactic gradient. As
a result, the neutrophils are directed towards the damaged
epithelium, where commensal bacteria are triggering the
intestinal wall.
LTB4, produced by LTA4H, is a powerful chemoattractant for
neutrophils and is implicated in several chronic inflammatory
disorders.33 LTA4H has recently been shown to be capable of
degrading PGP, thereby acting as a both a proinflammatory and
anti-inflammatory enzyme.27 Enhanced expression of LTB4 in
intestinal mucosa from patients with IBD has been reported.34
LTA4H activity in inflamed intestinal tissue may therefore be
involved in limiting PGP levels. The intestinal levels of LTB4 in
the patients with IBD in this study were similar to those in colo-
rectal cancer controls, which indicates that there was no increase
in LTA4H activity in IBD.
N-Ac-PGP is a far more potent chemoattractant for neutro-
phils than PGP.7 Incubation of IBD PMN-conditioned medium
Figure 5 Protease expression and
proline–glycine–proline (PGP) levels in
dextran sodium sulfate (DSS)-induced
colitis. (A) Immunohistochemistry of
intestinal matrix metalloproteinase 8
(MMP8), MMP9 and prolyl
endopeptidase (PE) (and negative
control) on consecutive intestinal
sections of a DSS-treated huCXCR2
knock-in mouse. Original magnification
×400. Intestinal N-Ac-PGP (B) and PGP
(C) levels in DSS-induced colitis,
expressed as ng (N-Ac-)PGP/g
intestinal tissue. All values are mean
+SEM (n=3–8). No significant
differences were detected, although
there was a strong trend towards
increased N-Ac-PGP levels at day 8
(versus day 0, p=0.09, unpaired t-test).
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resulted mainly in N-Ac-PGP formation from collagen type I,
indicating that IBD neutrophils also release the enzyme neces-
sary for acetylation of PGP. Recent work by our group shows
that the PMNs isolated from peripheral blood from patients
with IBD (also used in this study) have increased migratory cap-
acities towards CXCL8 compared with healthy control PMNs,
probably due to the increased expression of CXCR1 and
CXCR2 (Overbeek et al, unpublished work). Therefore PGP
levels, and especially N-Ac-PGP levels, may play an important
role in neutrophilic infiltration in IBD, as neutrophils from
patients with IBD may be more strongly attracted to (N-Ac-)
PGP.
To study the pathophysiological role of PGP in neutrophilic
inflammation in the colon, we used DSS-induced colitis in
mice. This widely used IBD model depends largely on MMP9
protease activity, as MMP9-deficient mice are resistant to
DSS-induced colonic inflammation,15 and MMP inhibition
reduced clinical features.16 With regard to the other compo-
nents involved in the PGP generation cascade, there were strik-
ing similarities to human IBD. There was an increase in active
MMP8 in colonic tissue from DSS-treated mice, and PE was
present. There was a strong trend towards increased (N-Ac-)
PGP levels. DSS-induced colitis is characterised by a large
CXCR2-dependent influx of neutrophils17 18 and is therefore
highly suitable for studying the role of PGP in neutrophilic
infiltration in the intestine. Neutralisation of PGP by daily treat-
ment with PGP antibodies or the PGP antagonist, RTR, led to
a significant reduction in the DAI and reduced shortening of
the colon. Moreover, PGP neutralisation led to a significant
reduction in infiltrating neutrophils in the intestine of
DSS-treated mice.
PGP induces the release of both CXCL8 and MMP9 of human
PMNs in vitro,20 35 and an increase in CXCL1 was seen on
N-Ac-PGP-mediated neutrophilic infiltration in the lung.23
Interestingly, we found that the DSS-induced elevation of both
CXCL1 and CXCL2 in the intestine was reduced by PGP neutral-
isation. Also, PGP neutralisation in DSS-induced colitis led to a
significant reduction in elevated intestinal MMP9 levels. This
suggests that PGP-induced activation of neutrophils, reflected by
increased CXCL1, CXCL2 and MMP9 levels, also occurs in the
intestine. A more profound activation of neutrophils by
N-Ac-PGP in the local intestinal micro environment of patients
with IBD or DSS-treated mice may explain the beneficial effect of
PGP neutralisation on intestinal inflammation in IBD.
In conclusion, both the proteolytic cascade that generates
PGP from collagen and (N-Ac-)PGP itself are present in the
intestine (figure 7). (N-Ac-)PGP-guided neutrophilic infiltration,
either by a direct chemotactic effect on circulating neutrophils
or activation of resident immune cells, plays an important role
in intestinal inflammation. This indicates a vicious circle of
neutrophil-mediated intestinal collagen proteolysis and subse-
quent PGP-guided infiltration of neutrophils in the intestine,
and opens up new approaches to the treatment of sustained
inflammation in IBD.
Figure 6 Proline–glycine–proline (PGP) neutralisation in dextran sodium sulfate (DSS)-induced colitis. The Disease Activity Index (A) and colonic
length (B) of huCXCR2 knock-in mice treated with 1.5% (w/v) DSS for 5 days, and daily intravenous injections of arginine–threonine–arginine (RTR)
with phosphate-buffered saline (PBS) as control, or PGP antibody with isotype antibody as control, and non-DSS controls. (C) Histopathological
scoring and (D) representative images of H&E-stained intestinal sections of all groups. (E) Representative images of neutrophil (LY-6B.2)
immunohistochemistry on intestinal sections of DSS-treated animals treated with RTR, PBS, PGP antibody and isotype antibody. (F) Myeloperoxidase
(MPO) levels in intestinal tissue homogenates of all groups as a measurement of neutrophil infiltration. Original magnifications ×200. All values are
mean+SEM (n=8). Significance of differences determined by two-tailed Student t test: *p<0.05; **p<0.01, ***p<0.001.
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